Management of Mast Cell Activation Syndrome with Cromolyn Sodium

Introduction to Cromolyn Sodium Formulations

The American Academy of Allergy, Asthma, and Immunology recommends cromolyn sodium nasal spray for allergic rhinitis, which works purely as a topical agent that inhibits mast cell degranulation locally in the nasal mucosa, preventing release of allergic and inflammatory mediators 2, 3
The European Academy of Allergy and Clinical Immunology states that cromolyn sodium nasal spray has no evidence of benefit for vasomotor rhinitis, NARES, or nasal polyposis 2, 3

The American College of Allergy, Asthma, and Immunology suggests starting with 100 mg four times daily and gradually increasing over 1-2 weeks to target dose of 200 mg four times daily for systemic MCAS symptoms, which require systemic mediator blockade, not localized nasal treatment 1
The guideline recommends that patients must understand this is preventive therapy requiring at least 1 month before assessing efficacy, as it does not provide acute symptom relief 1

The American Academy of Allergy, Asthma, and Immunology notes that oral cromolyn effectively reduces gastrointestinal manifestations, such as abdominal bloating, cramping, diarrhea, nausea, and vomiting, in patients with MCAS 1
The European Academy of Allergy and Clinical Immunology states that oral cromolyn may extend benefit to neuropsychiatric symptoms, such as headache, poor concentration, memory problems, and brain fog, in controlled studies 1

The American College of Allergy, Asthma, and Immunology recommends combining cromolyn with H1 and H2 antihistamines, such as cetirizine, loratadine, and famotidine, for comprehensive mediator blockade in patients with MCAS 1, 4
The guideline suggests considering leukotriene receptor antagonists, such as montelukast, for additional anti-inflammatory coverage if symptoms persist 1, 4

The American Academy of Allergy, Asthma, and Immunology notes that cromolyn has an excellent safety profile with minimal drug interactions, making it safe to combine with other medications 1
The European Academy of Allergy and Clinical Immunology states that cromolyn is safe in pregnancy and very young children due to lack of significant systemic toxicity 2, 3
The guideline recommends assessing efficacy after 4-6 weeks of maximum dosing and considering alternative or additional therapies if no response after 1 month at target dose 1